WINDTREE THERAPEUTICS INC /DE/ Net Income (Loss) Available to Common Stockholders, Diluted
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$39.71 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2017-03-31
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for the quarter ending 2015-12-31 was -$10.38M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for the quarter ending 2015-09-30 was -$21.70M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for the quarter ending 2015-06-30 was -$11.79M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for the quarter ending 2014-12-31 was -$12.43M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for fiscal 2016 was -$39.71M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for fiscal 2015 was -$56.02M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for fiscal 2014 was -$47.85M.
- WINDTREE THERAPEUTICS INC /DE/ net income (loss) available to common stockholders, diluted for fiscal 2013 was -$45.22M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$39.71M 10-K · filed 2017-03-31 | |||
| 2015-12-31 | -$10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$32.08M derived: sum of 2 quarters · filed 2017-03-31 | -$43.87M derived: sum of 3 quarters · filed 2017-03-31 | -$56.02M 10-K · filed 2017-03-31 |
| 2015-09-30 | -$21.70M 10-Q · filed 2015-11-05 | -$33.49M derived: sum of 2 quarters · filed 2015-11-05 | -$45.64M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$11.79M 10-Q · filed 2015-08-10 | -$23.94M 10-Q · filed 2015-08-10 | ||
| 2014-12-31 | -$12.43M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$23.76M derived: sum of 2 quarters · filed 2016-03-29 | -$35.83M derived: sum of 3 quarters · filed 2016-03-29 | -$47.85M 10-K · filed 2016-03-29 |
| 2014-09-30 | -$11.32M 10-Q · filed 2015-11-05 | -$23.39M derived: sum of 2 quarters · filed 2015-11-05 | -$35.42M 10-Q · filed 2015-11-05 | |
| 2014-06-30 | -$12.07M 10-Q · filed 2015-08-10 | -$23.92M 10-Q · filed 2015-08-10 | ||
| 2013-12-31 | -$10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$22.43M derived: sum of 2 quarters · filed 2015-03-16 | -$33.55M derived: sum of 3 quarters · filed 2015-03-16 | -$45.22M 10-K · filed 2015-03-16 |
| 2013-09-30 | -$12.22M 10-Q · filed 2014-11-07 | -$23.34M derived: sum of 2 quarters · filed 2014-11-07 | -$35.01M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | -$11.12M 10-Q · filed 2014-08-07 | -$23.85M 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | -$6.82M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$20.16M derived: sum of 2 quarters · filed 2015-03-16 | -$27.30M derived: sum of 3 quarters · filed 2015-03-16 | -$37.31M 10-K · filed 2015-03-16 |
| 2012-09-30 | -$13.35M 10-Q · filed 2013-11-12 | -$20.48M derived: sum of 2 quarters · filed 2013-11-12 | -$30.50M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | -$7.14M 10-Q · filed 2013-08-08 | -$17.15M 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |